CoChat

Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

There is currently much interest in defining how the microbiota shapes immune responses in the context of cancer. Various studies in both mice and humans have associated particular commensal species with better (or worse) outcomes in different cancer types and following treatment with cancer immunotherapies. However, the mechanisms involved remain ill-defined and even controversial. In this Viewpoint, Nature Reviews Immunology has invited six eminent scientists in the field to share their thoughts on the key questions and challenges for the field.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41577-020-0374-6

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Cited by

See all 81

Metadata

Authors
Finlay, B. B., Goldszmid, R., Honda, K., Trinchieri, G., Wargo, J., & Zitvogel, L.
Affiliations
  • University of British Columbia (CA)
  • National Institutes of Health (US)
  • Keio University (JP)
  • The University of Texas MD Anderson Cancer Center (US)
  • Inserm (FR)
Corresponding author
  • Finlay, B. Brett
  • Goldszmid, Romina
  • Honda, Kenya
  • Trinchieri, Giorgio
  • Wargo, Jennifer
  • Zitvogel, Laurence
Venue
Nature Reviews Immunology
Published
2020-07-13
Volume
20
Issue
9
Pages
522-528
ISSN
  • 1474-1733 (ISSN-L)
  • 1474-1741
OpenAlex
W3041520229
Cited by
81
References
56
Citations by year
2026: 3 · 2025: 10 · 2024: 9 · 2023: 16 · 2022: 16 · 2021: 23 · 2020: 4
FWCI
1.58
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature reviews. Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Agence Nationale de la Recherche (ANR-16-RHUS-0008)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
gut microbiota, cancer immunotherapy, commensal bacteria, host-microbe interactions, antitumor immunity, myeloid cells, inflammation, innate immunity, inflammatory cytokines, interferon, carcinogenesis, microbiota modulation, gnotobiotic models, microbiota transplantation, microbiota-based therapy
MeSH terms
Animals, Humans, Immunotherapy, Neoplasms, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Can we harness the microbiota to enhance the efficacy of cancer immunotherapy? https://app.cochat.ai/papers/10.1038/s41577-020-0374-6
The paper
Finlay, B. B., Goldszmid, R., Honda, K., Trinchieri, G., Wargo, J., & Zitvogel, L. (2020). Can we harness the microbiota to enhance the efficacy of cancer immunotherapy? Nature Reviews Immunology. https://doi.org/10.1038/s41577-020-0374-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.